miR Scientific

Rensselaer,  NY 
United States
  • Booth: 4226

miR Scientific LLC (www.mirscientific.com) is a precision bioscience company that has developed the miR Scientific Disease Management Platform™, a set of proprietary, non-invasive liquid biopsy urine tests that not only detect urological cancers with high accuracy, but also provide information on their severity and aggressiveness, potentially allowing for more accurate, precise and effective treatment of these cancers thereby optimizing the outcome of life-changing interventions and impacting the standard of care. We aim to improve day-to-day care for patients and positively impact the cost of healthcare for payors, employers and other stakeholders worldwide.